World Library  
Flag as Inappropriate
Email this Article

HACEK endocarditis

Article Id: WHEBN0000467649
Reproduction Date:

Title: HACEK endocarditis  
Author: World Heritage Encyclopedia
Language: English
Subject: Rickettsia africae, Rickettsia honei, Rickettsia japonica, Helicobacter cellulitis, Serratia infection
Collection: Bacteria
Publisher: World Heritage Encyclopedia
Publication
Date:
 

HACEK endocarditis

The HACEK organisms are a group of human flora, living in the oral-pharyngeal region.[2]

The bacteria were originally grouped because they were thought to be a significant cause of [1]

Contents

  • Organisms 1
  • Presentation 2
  • Treatment 3
  • References 4

Organisms

HACEK originally referred to

  1. ^ a b c d e Nørskov-Lauritsen, N (Apr 2014). "Classification, identification, and clinical significance of haemophilus and aggregatibacter species with host specificity for humans". Clinical Microbiology Reviews 27 (2): 214–40.  
  2. ^ Feder HM, Jr; Roberts, JC; Salazar, J; Leopold, HB; Toro-Salazar, O (Jun 2003). "HACEK endocarditis in infants and children: two cases and a literature review.". The Pediatric Infectious Disease Journal 22 (6): 557–62.  
  3. ^ Raza, SS; Sultan, OW; Sohail, MR (Aug 2010). "Gram-negative bacterial endocarditis in adults: state-of-the-heart.". Expert review of anti-infective therapy 8 (8): 879–85.  
  4. ^ Chambers, ST; Murdoch, D; Morris, A; Holland, D; Pappas, P; Almela, M; Fernández-Hidalgo, N; Almirante, B; Bouza, E; Forno, D; del Rio, A; Hannan, MM; Harkness, J; Kanafani, ZA; Lalani, T; Lang, S; Raymond, N; Read, K; Vinogradova, T; Woods, CW; Wray, D; Corey, GR; Chu, VH; International Collaboration on Endocarditis Prospective Cohort Study, Investigators (2013). "HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort.". PLoS ONE 8 (5): e63181.  
  5. ^ a b c d Sen Yew, H; Chambers, ST; Roberts, SA; Holland, DJ; Julian, KA; Raymond, NJ; Beardsley, J; Read, KM; Murdoch, DR (Jun 2014). "Association between HACEK bacteraemia and endocarditis". Journal of medical microbiology 63 (Pt 6): 892–5.  
  6. ^ a b c Wassef, N; Rizkalla, E; Shaukat, N; Sluka, M (May 15, 2013). "HACEK-induced endocarditis". BMJ case reports 2013: bcr2012007359.  
  7. ^ [1], eMedicine, HACEK organism infection. June 2005.

References

The treatment of choice for HACEK organisms in endocarditis is ceftriaxone, a third generation cephalosporin and a β-Lactam antibiotic (as are the penicillins). Ampicillin (a penicillin) and low-dose gentamicin (an aminoglycoside) is another therapeutic option.[7]

Treatment

In addition to valvular infections in the heart, they can also produce other infections such as bacteremia, abscess, peritonitis, otitis media, conjunctivitis, pneumonia, arthritis, osteomyelitis, and periodontal infections.

All of these organisms are part of the normal oropharyngeal flora, which grow slowly (up to 14 days), prefer a carbon dioxide–enriched atmosphere, and share an enhanced capacity to produce endocardial infections, especially in young children. Collectively they account for 5–10% of cases of infective endocarditis involving native valves and are the most common gram-negative cause of endocarditis among people who do not use IV drugs. They have been a frequent cause of culture-negative endocarditis. Culture negative refers to an inability to produce a colony on regular agar plates; this is because these bacteria are fastidious (requiring a specific nutrient).

Presentation

A list of HACEK organisms:

[6][5][4] but recent papers are using the new classification.[3]

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.